ISB News

Best Ever Valerie Logan Lunch: $120K Raised

The 5th Annual Valerie Logan Luncheon, which took place on Nov. 29, was our most successful yet, having raised $120,000 for ISB’s education programs. There were a few tear-jerker moments, including when Lee Hood interviewed some students: Sara Michelassi, who will graduate next spring with her high school diploma AND her AA in science from North Seattle College, said that she’s always dreamed of working in a lab, “but I doubted if that dream was achievable, because I thought I needed connections or lots of money in order to land such a competitive internship. But ISB showed me that everyone deserves the opportunity to pursue their dreams, no matter their status.” The double whammy was when Sara expressed her gratitude for having a paid internship, which helped to support her family.

Thank you to our sponsors!

Presenting Sponsor: Sabey Corporation
Platinum Sponsor: Aron M. Thompson
Gold Sponsors: The Boeing Co., Muckleshoot Charity Fund, Kidder Mathews, Douglas Howe & Robin DuBrin, and Providence Health & Services
Silver Sponsors: Arthur J. Gallagher & Co., Tulalip Tribes Charitable Fund, and Kilroy Realty

Read emcee Patti Payne’s followup column in the Puget Sound Business Journal.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on.

  • Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

    In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.

  • ISB Researchers Find a Chink in the Armor of Tuberculosis Pathogen

    By using a computer model to understand the adaptions of Mycobacterium tuberculosis (Mtb), the pathogen that causes tuberculosis, researchers at ISB have identified a network within Mtb that allows it to tolerate and resist drug therapies. This work is published in Cell Reports.